Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Rogueda

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Expert Opinion on Drug Delivery|November 22, 2005
Novel hydrofluoroalkane suspension formulations for respiratory drug deliveryPhilippe Rogueda
Pharmaceutical Research|May 21, 2005
Surface energy and interparticle forces correlations in model pMDI formulationsDaniela Traini, Philippe Rogueda, Paul Young, et al.
Therapeutic Delivery|August 8, 2013
Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalersJagdeep Shur, Chonladda Pitchayajittipong, Philippe Rogueda, et al.
AAPS Pharmscitech|May 7, 2008
Determination of reference ultrasound parameters for model and hydrofluoroalkane propellants using high-resolution ultrasonic spectroscopySusan Hoe, Paul M Young, Philippe Rogueda, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 5, 2004
Investigation of the molecular interactions in a pMDI formulation by atomic force microscopyRoya Ashayer, Paul F Luckham, Sivasegaram Manimaaran, et al.
Pharmaceutical Research|November 15, 2006
In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalersDaniela Traini, Paul M Young, Philippe Rogueda, et al.
The Journal of Pharmacy and Pharmacology|August 14, 2012
Twenty years of HFA pMDI patents: facts and perspectivesPhilippe Rogueda, Arthur Lallement, Daniela Traini, et al.
Expert Opinion on Pharmacotherapy|July 1, 2011
Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?Rania O Salama, Paul M Young, Philippe Rogueda, et al.
Drug Development and Industrial Pharmacy|March 9, 2016
Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulationMichele Pozzoli, Philippe Rogueda, Bing Zhu, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Expert Opinion on Drug Delivery|November 22, 2005
Novel hydrofluoroalkane suspension formulations for respiratory drug deliveryPhilippe Rogueda
Pharmaceutical Research|May 21, 2005
Surface energy and interparticle forces correlations in model pMDI formulationsDaniela Traini, Philippe Rogueda, Paul Young, et al.
Therapeutic Delivery|August 8, 2013
Effect of processing history on the surface interfacial properties of budesonide in carrier-based dry-powder inhalersJagdeep Shur, Chonladda Pitchayajittipong, Philippe Rogueda, et al.
AAPS Pharmscitech|May 7, 2008
Determination of reference ultrasound parameters for model and hydrofluoroalkane propellants using high-resolution ultrasonic spectroscopySusan Hoe, Paul M Young, Philippe Rogueda, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 5, 2004
Investigation of the molecular interactions in a pMDI formulation by atomic force microscopyRoya Ashayer, Paul F Luckham, Sivasegaram Manimaaran, et al.
Pharmaceutical Research|November 15, 2006
In vitro investigation of drug particulates interactions and aerosol performance of pressurised metered dose inhalersDaniela Traini, Paul M Young, Philippe Rogueda, et al.
The Journal of Pharmacy and Pharmacology|August 14, 2012
Twenty years of HFA pMDI patents: facts and perspectivesPhilippe Rogueda, Arthur Lallement, Daniela Traini, et al.
Expert Opinion on Pharmacotherapy|July 1, 2011
Advances in drug delivery: Is triple therapy the future for the treatment of chronic obstructive pulmonary disease?Rania O Salama, Paul M Young, Philippe Rogueda, et al.
Drug Development and Industrial Pharmacy|March 9, 2016
Dry powder nasal drug delivery: challenges, opportunities and a study of the commercial Teijin Puvlizer Rhinocort device and formulationMichele Pozzoli, Philippe Rogueda, Bing Zhu, et al.
Pageof 1